Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer

Shama Prasada Kabekkodu, Sanjiban Chakrabarty, Supriti Ghosh, Angela Brand, Kapaettu Satyamoorthy*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)100-115
Number of pages16
JournalPublic Health Genomics
Volume20
Issue number2
DOIs
Publication statusPublished - 2017

Keywords

  • Cervical cancer
  • Epigenetics
  • Risk factors
  • Personalized medicine
  • POTENTIAL PROGNOSTIC MARKER
  • PAPILLOMAVIRUS TYPE-16 DNA
  • SQUAMOUS-CELL CARCINOMA
  • INTRAEPITHELIAL NEOPLASIA
  • TUMOR-SUPPRESSOR
  • DOWN-REGULATION
  • ABERRANT METHYLATION
  • EPIGENETIC MECHANISM
  • PROMOTER METHYLATION
  • SOCIOECONOMIC-STATUS

Cite this